arrow
C

Christopher C. Coss

pharmacology
H指数:25
被引数:2,332

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fc gamma receptor binding modulates IgG clearance in cancer cachexia

Fcγ受体结合调节癌症恶病质中IgG的清除

2026-03-310
OAAI
Natural product target identification of wheldone, a fungal metabolite, as a KIF11 inhibitor in ovarian cancer using the DiffPOP (Differential Protein Precipitation) method.

利用DiffPOP(差异蛋白质沉淀)方法,对作为卵巢癌KIF11抑制剂的真菌代谢物wheldone进行天然产物靶点鉴定。

2026-03-230
OAAI
A Novel Mouse Model to Identify Antigen-Specific Immune Responses in Pancreatic Cancer Cachexia

一种新型小鼠模型,用于识别胰腺癌恶病质中的抗原特异性免疫应答

Cancers
IF4.4
2026-02-110
OAAI
Valine–Niclosamide for Treatment of Androgen Receptor Splice Variant-Positive Hepatocellular Carcinoma

缬氨酸–氯硝柳胺用于治疗雄激素受体剪接变异体阳性肝细胞癌

2025-08-200
PRE
Early Acute Kidney Injury and Its Association With Survival in Patients With Metastatic Non-Small-Cell Lung Cancer Treated With Front-Line Immunotherapy-Based Therapies

早期急性肾损伤及其与接受一线免疫疗法治疗的转移性非小细胞肺癌患者生存期的关联

2025-07-280
OAAI
Potent estrogen receptor β agonists with inhibitory activity in vitro, fail to suppress xenografts of endocrine-resistant cyclin-dependent kinase 4/6 inhibitor-resistant breast cancer cells

具有体外抑制活性的有效雌激素受体 β 激动剂不能抑制内分泌耐药细胞周期蛋白依赖性激酶4/6抑制剂耐药乳腺癌细胞的异种移植

2025-03-260
OAAI
The elucidation of species-specific receptor pharmacology: A case study using subtype-selective para- and meta-carborane estrogen receptor agonists
2025-01-011
PRE
Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical models
2024-06-170
OAAI
Physical Activity Decreases Inflammation and Delays the Development of Obesity-Associated Pancreatic Ductal Adenocarcinoma

体力活动减少炎症并延缓肥胖相关胰腺导管腺癌的发展

2024-05-222
PRE
Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia
2024-04-221
OA
Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia
2024-01-011
OAAI
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy

血清白蛋白: 免疫检查点抑制剂单药治疗而非化学免疫治疗获益的早期预后指标

2022-06-0121
OAAI